Managing Adverse Events of Novel Antibody-Drug Conjugates in Breast Cancer

Do you know the best practice strategies for preventing and managing adverse events with antibody-drug conjugates (ADCs) in breast cancer?    Credit available for this activity expires: 6/27/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993692?ecd=bdc_podcast_libsyn_mscpedu